Cadonilimab (AK104) 是一种靶向PD1/CTLA4的 IgG1 支架 Fc 工程人源化抗体。Cadonilimab 可用于转移性宫颈癌的研究。
| 生物活性 | Cadonilimab (AK104) is a targetingPD1/CTLA4IgG1scaffold Fc-engineered humanized antibody. Cadonilimab can be used for researching metastatic cervicalcancer[1][2]. |
| IC50& Target | |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com